Skip to main content
. 2018 May 20;131(10):1199–1205. doi: 10.4103/0366-6999.231528

Table 1.

General situations of different SBP trajectory groups

Parameter* Low-stable group (n = 864) Moderate-stable group (n = 1980) Moderate increasing group (n = 609) Elevated decreasing group (n = 679) Elevated stable group (n = 424) Total (n = 4556) P
Age (years) 49.25 ± 9.47 53.09 ± 8.96a,‡ 56.86 ± 7.54a,c 55.82 ± 8.68a,b 58.18 ± 7.53a,b 53.75 ± 9.15 <0.001
Male, n (%) 657 (76.0) 1625 (82.1) 496 (81.4) 560 (82.5) 345 (81.4) 3683 (80.8) 0.004
SBP_06 (mmHg) 115.64 ± 11.29 131.27 ± 12.30a 135.76 ± 12.26a,b 159.65 ± 12.27a,b 159.23 ± 15.45a,b,d 135.64 ± 19.36 <0.001
SBP_14 (mmHg) 123.18 ± 12.38 140.78 ± 12.47a 167.51 ± 12.60a,b 143.98 ± 13.06a,b,c 173.94 ± 13.12a,b,c,d 144.14 ± 20.12 <0.001
SBP14–06 (mmHg) 7.16 ± 16.99 9.57 ± 18.11 31.67 ± 17.12a,b −15.17 ± 17.04a,b,c 13.71 ± 19.78a,b,c,d 8.76 ± 21.70 <0.001
DBP_06 (mmHg) 76.78 ± 8.30 84.07 ± 8.83a 85.24 ± 9.08a 96.11 ± 11.50a,b,c 93.57 ± 11.76a,b,c 85.53 ± 11.34 <0.001
DBP_14 (mmHg) 75.90 ± 8.93 82.19 ± 9.26a 87.30 ± 11.15a,b 83.81 ± 10.06a,b,c 90.27 ± 12.21a,b,c,d 82.56 ± 10.73 <0.001
DBP14–06 (mmHg) −1.12 ± 11.04 −1.95 ± 11.40 2.12 ± 12.83a,b −12.49 ± 12.23a,b,c −3.59 ± 14.60c,d −2.93 ± 12.84 <0.001
SBP slope 1.48 ± 4.26 1.69 ± 4.64 7.72 ± 4.07a,b −4.73 ± 4.40a,b,c 3.03 ± 5.44a,b,c,d 1.63 ± 5.63 <0.001
FBG (mmol/L) 9.24 ± 3.14 9.03 ± 2.82 9.33 ± 3.01 8.71 ± 2.33a,c 9.31 ± 2.99d 9.09 ± 2.86 <0.001
TC (mmol/L) 5.11 ± 1.14 5.20 ± 1.21 5.10 ± 1.14 5.35 ± 1.20a,b,c 5.24 ± 1.29a,c 5.19 ± 1.20 0.001
HDL-C (mmol/L) 1.50 ± 0.38 1.53 ± 0.39 1.53 ± 0.43 1.57 ± 0.45a 1.55 ± 0.42 1.53 ± 0.41 0.025
LDL-C (mmol/L) 2.36 ± 0.90 2.41 ± 1.00 2.35 ± 0.92 2.39 ± 1.10 2.51 ± 1.04 2.40 ± 0.99 0.082
BMI (kg/m2) 25.08 ± 3.30 26.25 ± 3.31a 26.20 ± 3.16a 27.15 ± 3.31a,b,c 26.81 ± 3.50a,b,c 26.20 ± 3.36 <0.001
Exercise, n (%) 128 (14.8) 351 (17.7) 143 (23.5) 145 (21.4) 110 (25.9) 877 (19.2) 0.005
Smoking, n (%) 275 (31.8) 578 (29.2) 185 (30.4) 202 (29.7) 114 (26.9) 1354 (29.7) 0.382
Drinking, n (%) 127 (14.7) 328 (16.6) 118 (19.4) 122 (18.0) 69 (16.3) 764 (16.8) 0.061
Taking antihypertensive medications, n (%) 71 (8.2) 591 (29.8) 313 (51.4) 428 (63.0) 304 (71.7) 1707 (37.5) <0.001
Taking hypoglycemic agents, n (%) 453 (52.4) 1045 (52.8) 371 (60.9) 349 (51.4) 250 (59.0) 2468 (54.2) 0.019
Sulfonylureas, n (%) 28 (3.2) 63 (3.2) 27 (4.4) 25 (3.7) 20 (4.7) 163 (3.7) 0.393
Biguanide, n (%) 66 (7.6) 182 (9.2) 68 (11.2) 55 (8.1) 41 (9.7) 412 (9.0) 0.171
Glucosidase inhibitor, n (%) 10 (1.2) 14 (0.7) 6 (1.0) 8 (1.2) 5 (1.2) 43 (0.9) 0.686
Thiazolidine diones, n (%) 3 (0.3) 6 (0.3) 4 (0.7) 2 (0.3) 3 (0.7) 18 (0.4) 0.598
Noninsulin secretagogue, n (%) 9 (1.0) 8 (0.4) 6 (1.0) 4 (0.6) 3 (0.7) 30 (0.7) 0.292
Insulin, n (%) 50 (5.8) 96 (4.8) 35 (5.7) 33 (4.9) 20 (4.7) 234 (5.1) 0.770
Traditional Chinese medicine and others, n (%) 65 (7.5) 161 (8.1) 57 (9.4) 54 (8.0) 39 (9.2) 376 (8.3) 0.697
High cholesterol, n (%) 489 (56.6) 1295 (65.4) 412 (67.7) 484 (71.3) 290 (68.4) 2970 (65.2) <0.001

*SBP: Systolic blood pressure; DBP: Diastolic blood pressure; BMI: Body mass index; FBG: Fasting blood glucose; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol; TC: Total cholesterol; SBP14–06: 06 years and 14 years, SBP difference; DBP14–06: 06 years and 14 years, the difference between the DBP; Taking antihypertensive medications: Claimed to take medications in 06, 08, 10 or 12; Taking hypoglycaemic agents: Claimed to take hypoglycaemic agents in 06, 08, 10 or 12; Hypoglycaemic agents species using 2006 data; P value are for the difference comparison between the five groups; Superscript a, b, c, d refers to the difference in each group. Compared with low-stable group, aP<0.01; Compared with moderate-stable group, bP<0.01; Compared with moderate increasing group, cP<0.01; Compared with elevated decreasing group, dP<0.01.